Miltefosine for Mucosal Leishmaniasis

• Status: Completed
• Trial end date: 2006-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This trial will study miltefosine as a treatment for mucosal leishmaniasis.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AB Foundation
• Treatments: Miltefosine

Criteria

Inclusion Criteria:

• Mucosal leishmaniasis

Exclusion Criteria:

• Abnormal liver function tests (LFT)

• Abnormal kidney function test

• Concomitant diseases